Valentina T. Chiriac

Dr. Valentina T. Chiriac


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
VCValentina T. Chiriac
Valentina T. Chiriac
DLDaniel Corneliu Leucuta
Daniel Corneliu Leucuta
DMDaniela-Viorica Moșoiu
Daniela-Viorica Moșoiu
Context: Pain management is a constant struggle. Transcranial direct current stimulation (tDCS) is a neuromodulation technique with proved efficacy in chronic pain. Objective: The aim of the study is to provide a bibliometric perspective regarding articles on pain and tDCS. Having a visualized and systematically overview of publication trends, new research ideas could arise for clinicians. Methods: Articles on pain and tDCS were retrieved from Web of Science database. Using the R software version 4.1.2 and the “biblioshiny” R package, a quantitative and statistical analysis was performed. Time trend, number of publications, journals and authors, author country and institution, as well as citations and references were visualized. Results: A total of 554 publication fulfilled the criteria and were analyzed. The scientific production has been increasing over time with an annual growth of 17.1%. Brain Stimulation Journal and Journal of Pain are the leading journals regarding articles and citations. Fregni F. (83 articles) is the most prolific researcher with important authorship in the field. USA is the country with most authors involved in the topic (558 authors), whereas the leading institution is represented by Universidade Federal Rio Grande Do Sul (84 articles). Lefaucheur JP. article from 2017 has the maximum citations, while keywords in trend in the last three years are osteoarthritis and low back pain. Conclusion: This is the first bibliometric study that reflects the trends of tDCS in the field of pain. Journals as well as authors are limited and clustered. However the number of articles as well as number of citations are constantly increasing, supporting the idea that this is an emerging topic. The information obtained could be an important practical basis for future pain management research.

1 September 2025 in American Journal of Therapeutics
Verified
Journal Article
Closed access
VCValentina T. Chiriac
Valentina T. Chiriac
DMDaniela-Viorica Moşoiu
Daniela-Viorica Moşoiu
Background: Transcranial direct current stimulation (tDCS) has expanded its use for the treatment of chronic pain. Trials have proven the efficacy of tDCS, but there are still uncertainties over adverse effects (AEs). Areas of Uncertainty: There are no systematic data assessing tDCS safety profile in chronic pain conditions. Data Sources: A comprehensive systematic review was performed using PubMed and Web of Science databases. It included randomized sham-controlled clinical trials conducted in patients with different chronic pain conditions treated with tDCS. Based on the level of AEs reported, studies were classified as follows: type I, studies that provided numerical data on AEs; type II, studies that mentioned the occurrence of AEs; type III, studies that reported the absence of AEs; and type IV, studies that made no mention of AEs. Therapeutic Advances: The review included 141 studies: 60 type I, 21 type II, 34 type III, and 26 type IV. There were no significant differences in study design between studies that reported AEs quantitatively and those that reported the absence of AEs. Considering the number of studies that reported AEs quantitatively, the most documented for active versus sham groups were headache (18.86% vs. 19.23%) and tingling (15.43% vs. 19.23%). However, when considering frequency, the most common AEs observed for active versus sham groups were tingling (26.3% vs. 23.65%) and skin redness (17.6% vs. 9.56%). In comparing headache and tingling, no statistically significant difference between active and sham groups could be identified. Conclusions: In the present form of reporting AEs of tDCS in clinical studies involving patients with chronic pain, this procedure seems to be safe. Nevertheless, we identified diverse modalities of reporting and assessing AEs, which should raise the need for a standardized procedure in this domain.

1 March 2026 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
VCValentina T. Chiriac
Valentina T. Chiriac
DMDaniela-Viorica MoșOiu
Daniela-Viorica MoșOiu
Background: Pain remains a debilitating symptom for cancer patients, with over half of patients experiencing it during their illness. While pharmacological treatments are the primary approach, their limitations have prompted exploration of alternative methods, among them: non-invasive brain stimulation. Despite its safety, affordability, and growing evidence base, transcranial direct current stimulation remains underutilized in cancer care, and patient’s attitude toward its use is unknown. Methods: A cross-sectional survey was conducted at a single oncology center employing a mixed‑format questionnaire comprising single‑choice and multiple‑choice response options. It assessed the patients’ acceptance of pain therapies, and willingness to participate in clinical trials, with a focus on transcranial direct current stimulation as a pain management modality in oncology care. The study also examined associations between acceptance levels and factors such as pain presence, pain intensity and demographic characteristics. Results: Of the 179 oncology patients approached, 124 provided valid responses (usable response rate: 83.2%). In the study sample, the average age was 62 years, with a predominance of female participants. Colorectal and breast cancer were most common, and nearly half of the cohort had stage IV disease. Clinically significant pain (Numerical Rating Scale ≥ 4) was reported by 34.68% of patients, with a higher prevalence among those with metastatic disease (46.5% vs 24.2%, p = 0.009). Survey responses revealed polarized attitudes toward morphine, consistent acceptance of non-pharmacological treatments, and moderate support for transcranial direct current stimulation. Demographic, clinical, and pain-related variables did not significantly influence responses, nor the acceptance of tDCS. Conclusion: Gaining insight into patient perspectives on pain management is crucial for the effective integration of innovative, non-pharmacological approaches within supportive oncology care. The present study offers foundational data to guide subsequent research and inform strategies for clinical implementation.